A detailed history of Daiwa Securities Group Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 237 shares of JAZZ stock, worth $25,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
237
Previous 5,586 95.76%
Holding current value
$25,925
Previous $673,000 96.29%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$103.94 - $118.98 $555,975 - $636,424
-5,349 Reduced 95.76%
237 $25,000
Q1 2024

May 02, 2024

BUY
$115.19 - $132.77 $101,252 - $116,704
879 Added 18.67%
5,586 $673,000
Q4 2023

Jan 31, 2024

BUY
$114.26 - $136.0 $72,098 - $85,816
631 Added 15.48%
4,707 $579,000
Q3 2023

Nov 01, 2023

BUY
$122.0 - $145.31 $12,200 - $14,531
100 Added 2.52%
4,076 $528,000
Q2 2023

Jul 31, 2023

BUY
$122.5 - $147.16 $21,682 - $26,047
177 Added 4.66%
3,976 $493,000
Q1 2023

May 02, 2023

BUY
$133.98 - $160.47 $13,397 - $16,047
100 Added 2.7%
3,799 $556,000
Q4 2022

Feb 06, 2023

BUY
$129.72 - $159.85 $15,696 - $19,341
121 Added 3.38%
3,699 $589,000
Q3 2022

Nov 02, 2022

BUY
$126.59 - $161.18 $25,318 - $32,236
200 Added 5.92%
3,578 $477,000
Q2 2022

Aug 09, 2022

BUY
$141.59 - $168.66 $7,504 - $8,938
53 Added 1.59%
3,378 $527,000
Q1 2022

Apr 29, 2022

BUY
$129.64 - $160.7 $12,963 - $16,069
100 Added 3.1%
3,325 $518,000
Q4 2021

Feb 03, 2022

BUY
$119.87 - $145.67 $14,264 - $17,334
119 Added 3.83%
3,225 $411,000
Q3 2021

Nov 05, 2021

BUY
$128.64 - $184.79 $11,577 - $16,631
90 Added 2.98%
3,106 $404,000
Q2 2021

Aug 06, 2021

BUY
$160.2 - $186.42 $60,555 - $70,466
378 Added 14.33%
3,016 $536,000
Q1 2021

May 03, 2021

BUY
$150.19 - $173.5 $1,051 - $1,214
7 Added 0.27%
2,638 $434,000
Q4 2020

Feb 04, 2021

SELL
$140.71 - $165.05 $29,549 - $34,660
-210 Reduced 7.39%
2,631 $434,000
Q3 2020

Nov 02, 2020

BUY
$105.46 - $144.13 $20,986 - $28,681
199 Added 7.53%
2,841 $405,000
Q1 2020

May 14, 2020

BUY
$87.74 - $152.74 $15,179 - $26,424
173 Added 7.01%
2,642 $264,000
Q4 2019

Jan 31, 2020

SELL
$117.65 - $153.73 $4,941 - $6,456
-42 Reduced 1.67%
2,469 $360,000
Q3 2019

Nov 04, 2019

BUY
$125.18 - $143.24 $625 - $716
5 Added 0.2%
2,511 $322,000
Q2 2019

Jul 24, 2019

SELL
$125.55 - $144.48 $878 - $1,011
-7 Reduced 0.28%
2,506 $357,000
Q1 2019

Apr 26, 2019

SELL
$121.81 - $142.95 $3,410 - $4,002
-28 Reduced 1.1%
2,513 $359,000
Q4 2018

Feb 05, 2019

BUY
$115.94 - $166.74 $24,347 - $35,015
210 Added 9.01%
2,541 $315,000
Q1 2018

May 02, 2018

BUY
$135.59 - $157.16 $58,439 - $67,735
431 Added 22.68%
2,331 $352,000
Q4 2017

Feb 06, 2018

BUY
$131.06 - $150.39 $32,765 - $37,597
250 Added 15.15%
1,900 $256,000
Q3 2017

Nov 02, 2017

BUY
$142.62 - $155.6 $235,323 - $256,740
1,650
1,650 $241,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.86B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.